Literature DB >> 23765174

Melasma and laser treatment: an evidenced-based analysis.

Shlomit Halachmi1, Merete Haedersdal, Moshe Lapidoth.   

Abstract

The use of lasers in the treatment of melasma has been addressed in case reports, but there is no consensus in the literature regarding the safety, efficacy, or durability of laser-based treatments. Furthermore, given the potential risks of laser intervention in hyperpigmented skin, the relative risks and benefit of laser must be compared to more conservative and traditional treatment approaches. English language literature in which the main intervention was a light-based therapy and the target was melasma was analyzed. The study included only prospective, controlled studies which included at least 10 participants, and which presented the data with accepted objective and quantitative study metrics. Seven studies met the inclusion criteria. Two studies reported the response to melanin-targeting lasers and five reported the response to fractional photothermolysis. The response to lasers was not consistent among the reports. Adverse events including hyperpigmentation were reported in several studies. The durability of melasma improvement was limited in all cases where laser was used as monotherapy. In studies that compared laser to topical treatments, laser-based monotherapy failed to show benefit over topical treatments. This analysis suggests that the use of lasers for the treatment of melasma cannot be recommended, due to unpredictable safety and efficacy, time-limited clinical improvement, and no clear benefit over conventional treatments.

Entities:  

Mesh:

Year:  2013        PMID: 23765174     DOI: 10.1007/s10103-013-1318-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  24 in total

Review 1.  Melasma: a comprehensive update: part II.

Authors:  Vaneeta M Sheth; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

2.  Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma.

Authors:  Xi Zhou; Michael H Gold; Zhong Lu; Ying Li
Journal:  Dermatol Surg       Date:  2011-05-26       Impact factor: 3.398

3.  Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.

Authors:  Bertha Torres-Álvarez; Iraida G Mesa-Garza; Juan P Castanedo-Cázares; Cornelia Fuentes-Ahumada; Cuauhtémoc Oros-Ovalle; Josefina Navarrete-Solis; Benjamin Moncada
Journal:  Am J Dermatopathol       Date:  2011-05       Impact factor: 1.533

4.  Melasma induced by oral contraceptive drugs.

Authors:  S Resnik
Journal:  JAMA       Date:  1967-02-27       Impact factor: 56.272

5.  A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.

Authors:  Tess Mauricio; Yoram Karmon; Alain Khaiat
Journal:  J Cosmet Dermatol       Date:  2011-12       Impact factor: 2.696

6.  Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study.

Authors:  Bas S Wind; Marije W Kroon; Arne A Meesters; Johan F Beek; J P Wietze van der Veen; Ludmila Nieuweboer-Krobotová; Jan D Bos; Albert Wolkerstorfer
Journal:  Lasers Surg Med       Date:  2010-09       Impact factor: 4.025

7.  The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study.

Authors:  Mario A Trelles; Mariano Velez; Michael H Gold
Journal:  J Drugs Dermatol       Date:  2010-04       Impact factor: 2.114

Review 8.  The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register.

Authors:  Jacob Levitt
Journal:  J Am Acad Dermatol       Date:  2007-04-27       Impact factor: 11.527

9.  Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma.

Authors:  R J Lutfi; M Fridmanis; A L Misiunas; O Pafume; E A Gonzalez; J A Villemur; M A Mazzini; H Niepomniszcze
Journal:  J Clin Endocrinol Metab       Date:  1985-07       Impact factor: 5.958

Review 10.  Skin lightening preparations and the hydroquinone controversy.

Authors:  Zoe Diana Draelos
Journal:  Dermatol Ther       Date:  2007 Sep-Oct       Impact factor: 2.851

View more
  3 in total

1.  Treatment of facial post-burn hyperpigmentation using micro-plasma radiofrequency technology.

Authors:  Lian-Zhao Wang; Jin-Ping Ding; Ming-Yong Yang; Dian-Wei Chen; Bo Chen
Journal:  Lasers Med Sci       Date:  2014-09-11       Impact factor: 3.161

2.  Lasers are not Effective for Melasma in Darkly Pigmented Skin.

Authors:  Kabir Sardana; Vijay K Garg
Journal:  J Cutan Aesthet Surg       Date:  2014-01

3.  Combination of Hydroquinone and Fractional CO2 Laser versus Hydroquinone Monotherapy in Melasma Treatment: A Randomized, Single-blinded, Split-face Clinical Trial.

Authors:  Sanaz Nourmohammadi Abadchi; Farahnaz Fatemi Naeini; Elham Beheshtian
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.